May 9 (Reuters) - Effector Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* EFFECTOR THERAPEUTICS- HAD CASH, CASH EQUIVALENTS, AND
SHORT-TERM INVESTMENTS TOTALING $19.0 MILLION AS OF MARCH 31,
2023
* EFFECTOR THERAPEUTICS- ANTICIPATES THAT CURRENT CASH, CASH
EQUIVALENTS & SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO FUND
OPERATIONS INTO Q1 OF 2024
* QTRLY NET LOSS WAS $10.0 MILLION, OR $0.24 PER BASIC AND
DILUTED
SHARE
* Q1 EARNINGS PER SHARE VIEW $-0.14 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8jYvh6
Further company coverage: EFTR.O
((Reuters.Briefs@thomsonreuters.com;))